Learn About Neurapheresis™
Why CSF Matters
Cerebrospinal fluid is the body's natural protector of the brain and spinal cord—maintaining intracranial pressure, clearing metabolic waste, and delivering essential nutrients. When CSF balance is disrupted, the consequences can be catastrophic.
Pharaoh Neuro's Neurapheresis™ platform represents the next frontier in neurological care:
precision management of CSF to restore equilibrium and protect brain health in neurocritical patients.
precision management of CSF to restore equilibrium and protect brain health in neurocritical patients.
We don't just treat symptoms. We restore balance.
What's New
Featured Topic
PILLAR-XT Trial
There is a growing consensus that blood in the cerebrospinal fluid (CSF) is deleterious to outcomes in patients with aneurysmal subarachnoid hemorrhage. The extracorporeal filtration of subarachnoid hemorrhage via spinal catheter extension study evaluated the safety, tolerability, and filtration curve of blood and its lysis products from...
Featured Topic
Podcast: New potential treatment for brain bleeds from aneurysms and strokes
A DukeHealth neurosurgeon invented a breakthrough "NEURAPHERESIS" device for treating brain bleeds from strokes or aneurysms. It will likely save lives, improve quality of life, & may have many other future brain health uses. Watch Dr. Lad explain how it works.
Featured Topic
Podcast: New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup
In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing...
Meet the Team
Our leadership team is guided by science, shaped by experience, and focused on transforming neurocritical care.
Partners
Powered by investors who are committed to shaping the future of Neurapheresis™
The Pharaoh Neurapheresis™ system has only been used clinically under an investigation device exemption and has not been cleared or approved by the U.S. Food and Drug Administration (FDA) and is not authorized for sale or distribution in the United States.